Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
01 2022
Historique:
received: 03 08 2021
revised: 17 10 2021
accepted: 17 10 2021
pubmed: 25 10 2021
medline: 24 2 2022
entrez: 24 10 2021
Statut: ppublish

Résumé

Staphylococcus aureus (SA) has been extensively studied as causative microorganism of surgical prosthetic-valve infective endocarditis (IE). However, scarce evidence exists on SA IE after transcatheter aortic valve replacement (TAVR). Data were obtained from the Infectious Endocarditis After TAVR International Registry, including patients with definite IE after TAVR from 59 centres in 11 countries. Patients were divided into 2 groups according to microbiologic etiology: non-SA IE vs SA IE. SA IE was identified in 141 patients out of 573 (24.6%), methicillin-sensitive SA in most cases (115/141, 81.6%). Self-expanding valves were more common than balloon-expandable valves in patients presenting with early SA IE. Major bleeding and sepsis complicating TAVR, neurologic symptoms or systemic embolism at admission, and IE with cardiac device involvement (other than the TAVR prosthesis) were associated with SA IE (P < 0.05 for all). Among patients with IE after TAVR, the likelihood of SA IE increased from 19% in the absence of those risk factors to 84.6% if ≥ 3 risk factors were present. In-hospital (47.8% vs 26.9%; P < 0.001) and 2-year (71.5% vs 49.6%; P < 0.001) mortality rates were higher among patients with SA IE vs non-SA IE. Surgery at the time of index SA IE episode was associated with lower mortality at follow-up compared with medical therapy alone (adjusted hazard ratio 0.46, 95% CI 0.22-0.96; P = 0.038). SA IE represented approximately 25% of IE cases after TAVR and was associated with very high in-hospital and late mortality. The presence of some features determined a higher likelihood of SA IE and could help to orientate early antibiotic regimen selection. Surgery at index SA IE was associated with improved outcomes, and its role should be evaluated in future studies.

Sections du résumé

BACKGROUND
Staphylococcus aureus (SA) has been extensively studied as causative microorganism of surgical prosthetic-valve infective endocarditis (IE). However, scarce evidence exists on SA IE after transcatheter aortic valve replacement (TAVR).
METHODS
Data were obtained from the Infectious Endocarditis After TAVR International Registry, including patients with definite IE after TAVR from 59 centres in 11 countries. Patients were divided into 2 groups according to microbiologic etiology: non-SA IE vs SA IE.
RESULTS
SA IE was identified in 141 patients out of 573 (24.6%), methicillin-sensitive SA in most cases (115/141, 81.6%). Self-expanding valves were more common than balloon-expandable valves in patients presenting with early SA IE. Major bleeding and sepsis complicating TAVR, neurologic symptoms or systemic embolism at admission, and IE with cardiac device involvement (other than the TAVR prosthesis) were associated with SA IE (P < 0.05 for all). Among patients with IE after TAVR, the likelihood of SA IE increased from 19% in the absence of those risk factors to 84.6% if ≥ 3 risk factors were present. In-hospital (47.8% vs 26.9%; P < 0.001) and 2-year (71.5% vs 49.6%; P < 0.001) mortality rates were higher among patients with SA IE vs non-SA IE. Surgery at the time of index SA IE episode was associated with lower mortality at follow-up compared with medical therapy alone (adjusted hazard ratio 0.46, 95% CI 0.22-0.96; P = 0.038).
CONCLUSIONS
SA IE represented approximately 25% of IE cases after TAVR and was associated with very high in-hospital and late mortality. The presence of some features determined a higher likelihood of SA IE and could help to orientate early antibiotic regimen selection. Surgery at index SA IE was associated with improved outcomes, and its role should be evaluated in future studies.

Identifiants

pubmed: 34688853
pii: S0828-282X(21)00804-7
doi: 10.1016/j.cjca.2021.10.004
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-112

Informations de copyright

Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

David Del Val (D)

Québec Heart & Lung Institute, Laval University, Québec City, Québec, Canada.

Mohamed Abdel-Wahab (M)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Heart Centre, Segeberger Kliniken, Bad Segeberg, Germany.

Norman Mangner (N)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Herzzentrum Dresden, Technische Universität Dresden, Germany.

Eric Durand (E)

Normandie Univ, UNIROUEN, U1096, CHU Rouen, Department of Cardiology, FHU CARNAVAL, F-76000 Rouen, France.

Nikolaj Ihlemann (N)

Righospitalet, Copenhagen, Denmark.

Marina Urena (M)

Bichat Hôpital, Paris, France.

Costanza Pellegrini (C)

Deutsches Herzzentrum München, Munich, Germany.

Francesco Giannini (F)

Ospedale San Raffaele, Milan, Italy; Maria Cecilia Hospital, GVM Care and Research, Cotignola RA, Italy.

Tomasz Gasior (T)

Herzzentrum Dresden, Technische Universität Dresden, Germany.

Wojtek Wojakowski (W)

Medical University of Silesia, Katowice, Poland.

Martin Landt (M)

Heart Centre, Segeberger Kliniken, Bad Segeberg, Germany.

Vincent Auffret (V)

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR1099, F 35000 Rennes, France.

Jan Malte Sinning (JM)

Heart Centre Bonn, Bonn, Germany.

Asim N Cheema (AN)

St Michaels Hospital, Toronto, Ontario, Canada; Southlake Hospital, Newmarket, Ontario, Canada.

Luis Nombela-Franco (L)

Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Chekrallah Chamandi (C)

Hôpital Européen Georges-Pompidou, Paris, France.

Francisco Campelo-Parada (F)

Hôpital Rangueil, Toulouse, France.

Erika Munoz-Garcia (E)

Hospital Universitario Virgen de la Victoria, Malaga, Spain.

Howard C Herrmann (HC)

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Luca Testa (L)

IRCCS Policlinico San Donato, Milan, Italy.

Kim Won-Keun (K)

Kerckhoff Heart and Thorax Centre, Bad Nauheim, Germany.

Juan Carlos Castillo (JC)

Hospital Universitario Reina Sofia, Cordoba, Spain.

Alberto Alperi (A)

Hospital Universitario Central de Asturias, Oviedo, Spain.

Didier Tchetche (D)

Clinique Pasteur, Toulouse, France.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino, IRCCS and Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Milan, Italy.

Samir Kapadia (S)

Cleveland Clinic, Cleveland, Ohio, USA.

Stefan Stortecky (S)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland (on behalf of Swiss TAVI).

Ignacio Amat-Santos (I)

CIBERCV, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.

Harindra C Wijeysundera (HC)

Sunnybrook Health Science Centre, Toronto, Ontario, Canada.

John Lisko (J)

Emory University School of Medicine, Atlanta, Georgia, USA.

Enrique Gutiérrez-Ibanes (E)

Instituto de Investigación Universitaria Gregorio Marañon, Hospital Gregorio Marañón, Madrid, Spain.

Vicenç Serra (V)

Hospital Vall d'Hebron, Barcelona, Spain.

Luisa Salido (L)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Abdullah Alkhodair (A)

St Paul's Hospital, Vancouver, British Columbia, Canada.

Igor Vendramin (I)

University Hospital of Udine, Udine, Italy.

Tarun Chakravarty (T)

Cedars-Sinai Heart Institute, Los Angeles, California, USA.

Stamatios Lerakis (S)

Emory University School of Medicine, Atlanta, Georgia, USA; Mount Sinai Hospital, New York, New York, USA.

Victoria Vilalta (V)

Hospital Germans Trias i Pujol, Badalona, Spain.

Ander Regueiro (A)

Hospital Clinic, Barcelona, Spain.

Rafael Romaguera (R)

Hospital de Bellvitge, l'Hospitalet de Llobregat, Spain.

Utz Kappert (U)

Herzzentrum Dresden, Technische Universität Dresden, Germany.

Marco Barbanti (M)

AOU Policlinico Vittorio Emanuele, University of Catania, Catania, Italy.

Jean-Bernard Masson (JB)

Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.

Frédéric Maes (F)

Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Claudia Fiorina (C)

ASST-Spedali Civili di Brescia, Brescia, Italy.

Antonio Miceli (A)

Istituto Clinico Sant'Ambrogio, Milan, Italy; University Hospital Galway, Galway, Ireland.

Susheel Kodali (S)

Columbia University Medical Center, New York, New York, USA.

Henrique B Ribeiro (HB)

InCor, Heart Institute, University of São Paulo Medical School, Sao Paulo, Brazil; Hospital Samaritano Paulista, São Paulo, Brazil.

Jose Armando Mangione (JA)

Hospital Beneficencia Portuguesa, São Paulo, Brazil.

Fabio Sandoli de Brito (F)

InCor, Heart Institute, University of São Paulo Medical School, Sao Paulo, Brazil.

Guglielmo Mario Actis Dato (GM)

Ospedali Mauriziano, Torino, Italy.

Francesco Rosato (F)

Azienda Ospedaliera Santa Cocre e Carle, Cuneo, Italy.

Maria-Cristina Ferreira (MC)

Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil.

Valter Corriea de Lima (V)

Hospital São Francisco-Santa Casa de Porto Alegre, Porto Alegre, Brazil.

Alexandre Siciliano Colafranceschi (AS)

Hospital Pró-cardíaco, Rio de Janeiro, Brazil.

Alexandre Abizaid (A)

InCor, Heart Institute, University of São Paulo Medical School, Sao Paulo, Brazil.

Marcos Antonio Marino (MA)

Hospital Madre Teresa, Belo Horizonte, Brazil.

Vinicius Esteves (V)

Hospital Sao Luiz, São Paulo, Brazil.

Julio Andrea (J)

Clínica Sao Vicente, Rio de Janeiro, Brazil.

Roger R Godinho (RR)

Hospital Samaritano Paulista, São Paulo, Brazil.

Fernando Alfonso (F)

Hospital Universitario de La Princesa, Madrid, Spain.

Helene Eltchaninoff (H)

Normandie Univ, UNIROUEN, U1096, CHU Rouen, Department of Cardiology, FHU CARNAVAL, F-76000 Rouen, France.

Lars Søndergaard (L)

Righospitalet, Copenhagen, Denmark.

Dominique Himbert (D)

Bichat Hôpital, Paris, France.

Oliver Husser (O)

Deutsches Herzzentrum München, Munich, Germany; St-Johannes-Hospital, Dortmund, Germany.

Azeem Latib (A)

Ospedale San Raffaele, Milan, Italy; Montefiore Medical Center, New York, New York, USA.

Hervé Le Breton (H)

Univ Rennes, CHU Rennes, Inserm, LTSI - UMR1099, F 35000 Rennes, France.

Clement Servoz (C)

Hôpital Rangueil, Toulouse, France.

Isaac Pascual (I)

Hospital Universitario Central de Asturias, Oviedo, Spain.

Saif Siddiqui (S)

Clinique Pasteur, Toulouse, France.

Paolo Olivares (P)

Centro Cardiologico Monzino, IRCCS and Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Milan, Italy.

Rosana Hernandez-Antolin (R)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

John G Webb (JG)

St Paul's Hospital, Vancouver, British Columbia, Canada.

Sandro Sponga (S)

University Hospital of Udine, Udine, Italy.

Raj Makkar (R)

Cedars-Sinai Heart Institute, Los Angeles, California, USA.

Annapoorna S Kini (AS)

Mount Sinai Hospital, New York, New York, USA.

Marouane Boukhris (M)

Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.

Philippe Gervais (P)

Québec Heart & Lung Institute, Laval University, Québec City, Québec, Canada.

Axel Linke (A)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Herzzentrum Dresden, Technische Universität Dresden, Germany.

Lisa Crusius (L)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany; Herzzentrum Dresden, Technische Universität Dresden, Germany.

David Holzhey (D)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Josep Rodés-Cabau (J)

Québec Heart & Lung Institute, Laval University, Québec City, Québec, Canada; Hospital Clinic, Barcelona, Spain. Electronic address: josep.rodes@criucpq.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH